Publication:
Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteria

dc.contributor.authorSawaek Weerakieten_US
dc.contributor.authorPongamon Bunnagen_US
dc.contributor.authorBunyong Phakdeekitcharoenen_US
dc.contributor.authorSurapee Wansumrithen_US
dc.contributor.authorSuwannee Chanprasertyothinen_US
dc.contributor.authorRattiya Jultanmasen_US
dc.contributor.authorAmmarin Thakkinstianen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-24T01:42:59Z
dc.date.available2018-08-24T01:42:59Z
dc.date.issued2007-03-01en_US
dc.description.abstractBackground. Since insulin resistance and compensatory hyperinsulinemia are the major causes of the metabolic syndrome (MS) and are also the main pathophysiology of polycystic ovary syndrome (PCOS), PCOS women are at risk of MS. The aim of the present cross-sectional study was to determine the prevalence of MS in Asian women with PCOS using the International Diabetes Federation (IDF) criteria and to define the risk factors. Methods. One hundred and seventy women with PCOS were enrolled in the study from September 3, 2002 to June 14, 2005. A 75-g oral glucose tolerance test with plasma glucose and serum insulin levels was performed. Also, blood samples were examined for fasting triglycerides, high-density lipoprotein cholesterol and adiponectin levels. Results. The mean (±standard deviation) age, body mass index (BMI) and waist-to-hip ratio were 28.8 ± 5.9 years, 27.1 ± 7.0 kg/m2 and 0.85 ± 0.06, respectively. The prevalence of MS was 35.3%. Age, BMI, waist circumference and all metabolic parameters were higher in PCOS women with MS than in those without MS. MS prevalence increased with age, BMI and insulin resistance as determined by homeostasis model assessment (HOMA-IR), but not with adiponectin after BMI adjustment. Conclusions. According to the IDF criteria, one-third of the PCOS women had MS. This study also showed that age, BMI and HOMA-IR are important risk factors for MS. © 2007 Informa UK Ltd.en_US
dc.identifier.citationGynecological Endocrinology. Vol.23, No.3 (2007), 153-160en_US
dc.identifier.doi10.1080/09513590701214158en_US
dc.identifier.issn14730766en_US
dc.identifier.issn09513590en_US
dc.identifier.other2-s2.0-34147111346en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/24239
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34147111346&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titlePrevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteriaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34147111346&origin=inwarden_US

Files

Collections